Lipocine Stock In The News

LPCN -  USA Stock  

USD 1.01  0.04  3.81%

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Lipocine and other traded companies coverage. We help investors stay connected with Lipocine headlines for the 4th of December to make an informed investment decision based on correlating the impacts of news items on Lipocine Stock performance. Please note that trading solely based on the Lipocine hype is not for everyone as timely availability and quick action are needed to avoid losses. The value of Net Income Common Stock is estimated to slide to about (21.5 M).

Lipocine Timeline 

 
Refresh
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Lipocine headlines in addition to utilizing other, more conventional financial analysis modules. Additionally, see Lipocine Backtesting and Lipocine Hype Analysis.
Lipocine's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Lipocine investors visualize upcoming and past events in order to time the market based on Lipocine noise-free hype analysis.
Lipocine stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Lipocine earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Lipocine that is available to investors today. That information is available publicly through Lipocine media outlets and privately through word of mouth or via Lipocine internal channels. However, regardless of the origin, that massive amount of Lipocine data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lipocine news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lipocine relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lipocine's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lipocine alpha.

Lipocine Largest EPS Surprises

Earnings surprises can significantly impact Lipocine's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-06
2021-03-31-0.05-0.040.0120 
2020-11-10
2020-09-30-0.06-0.07-0.0116 
2021-11-10
2021-09-30-0.0425-0.030.012529 
2019-03-06
2018-12-31-0.1333-0.15-0.016712 
2021-08-05
2021-06-30-0.05-0.08-0.0360 
2014-03-31
2013-12-31-0.27-0.3-0.0311 
View All Earnings Estimates

Lipocine Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Lipocine Stock. The global stock market is bearish. About 65% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News
18th of November 2021
Purchase by Mahesh Patel of 25000 shares of Lipocine
at MacroaxisInsider 
Equities News
29th of October 2021
Lipocine gains 1.96 percent to Close at 1.04 on October 29 - Equities.com
at www.equities.com 
Equities News
20th of October 2021
Lipocine falls 1.74 percent on Moderate Volume October 20 - Equities.com
at www.equities.com 
Equities News
15th of October 2021
Lipocine falls 0.88 percent to Close at 1.13 on October 15 - Equities.com
at www.equities.com 
Equities News
4th of October 2021
Lipocine falls 1.89 percent on Moderate Volume October 4 - Equities.com
at www.equities.com 
Equities News
24th of September 2021
Lipocine falls 1.79 percent to Close at 1.10 on September 24 - Equities.com
at www.equities.com 
Simply Wall St News at Macroaxis
14th of September 2021
Is Lipocine Using Debt Sensibly - Simply Wall St
at simplywall.st 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lipocine without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Lipocine using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Lipocine Backtesting and Lipocine Hype Analysis. Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Lipocine Stock analysis

When running Lipocine price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine Lipocine value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.